AN ECONOMIC EVALUATION OF RANIBIZUMAB VERSUS AFLIBERCEPT FOR THE TREATMENT OF NEOVASCULAR (WET) AMD IN THE UNITED KINGDOM

被引：1

作者：

Malcolm, W. A. ^{[1
]}

Claxton, L. ^{[2
]}

Hodgson, R. ^{[3
]}

Taylor, M. ^{[2
]}

机构：

[1] Novartis UK, Frimley, England

[2] Univ York, York Hlth Econ Consortium, York YO10 5DD, N Yorkshire, England

[3] York Hlth Econ Consortium, York, N Yorkshire, England

来源：

VALUE IN HEALTH | 2015年 / 18卷 / 03期

关键词：

D O I：

10.1016/j.jval.2015.03.1057

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

PSS25

引用

页码：A183 / A183

页数：1

共 50 条

[41] ECONOMIC EVALUATION OF BEVACIZUMAB VERSUS RANIBIZUMAB IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION IN CHINA
Li, H.
Li, X.
Xie, F.
VALUE IN HEALTH, 2014, 17 (07) : A782 - A782
[42] Efficacy of intravitreal Aflibercept in patients with neovascular AMD who were previously treated with Ranibizumab based on a Treat and Extend protocol
Turksever, C.
Prunte, C.
Hatz, K.
ACTA OPHTHALMOLOGICA, 2015, 93
[43] Efficacy of Intravitreal Aflibercept in Patients with Neovascular AMD Who Were Previously Treated with Ranibizumab Based on a Treat and Extend Protocol
Turksever, Cengiz
Pruente, Christian
Hatz, Katja
OPHTHALMOLOGICA, 2016, 236 : 19 - 20
[44] Investigating visual and anatomical outcomes of patients treated with ranibizumab and aflibercept for wet macular degeneration in the United Kingdom over a 3 year period
Grinton, Michael
McKenna, Michael
Pushpoth, Sreekumari
Severn, Philip
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
[45] Ranibizumab for the treatment of wet AMD: a summary of real-world studies
Chong, V.
EYE, 2016, 30 (02) : 270 - 286
[46] Ranibizumab for the treatment of wet AMD: a summary of real-world studies
V Chong
Eye, 2016, 30 : 270 - 286
[47] Switching between ranibizumab and aflibercept for the treatment of neovascular age-related macular degeneration
Mantel, Irmela
Gillies, Mark C.
Souied, Eric H.
SURVEY OF OPHTHALMOLOGY, 2018, 63 (05) : 638 - 645
[48] Switch to Aflibercept in the Treatment of Neovascular AMD: One-Year Results in Clinical Practice
Pinheiro-Costa, Joao
Costa, Jose M.
Beato, Joao N.
Freitas-da-Costa, Paulo
Brandao, Elisete
Falcao, Manuel S.
Falcao-Reis, Fernando
Carneiro, Angela M.
OPHTHALMOLOGICA, 2015, 233 (3-4) : 155 - 161
[49] Change in choroidal thickness after intravitreal injection for treatment of neovascular age-related macular degeneration: Ranibizumab versus aflibercept
Kaya, F.
JOURNAL FRANCAIS D OPHTALMOLOGIE, 2017, 40 (10): : 832 - 838
[50] Six Months Intravitreal Ranibizumab Treatment in Neovascular AMD Patients Assessed With Multifocal ERG
Pedersen, K. B.
Moeller, F.
Solie, A.
Andreasson, S.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)

← 1 2 3 4 5 →